Markt Update 11/12/2013

De Amsterdamse aandelenbeurs is vanmorgen in de min geopend. Ook de andere Europese indices begonnen overwegend met kleine minnen.

Het sentiment blijft afwachtend doordat beleggers duidelijkheid missen over de afbouwplannen van het steunbeleid van de Amerikaanse Federal Reserve.

De Amsterdamse index noteerde kort na aanvang van de handel 0,2 procent lager op 384,72 punten. De MidKap bleef hetzelfde op 602,68 punten. De indices in Frankfurt en Londen verloren tot 0,2 procent. De Franse CAC 40-index bleef nagenoeg onveranderd.

Grootste verliezer in de AEX was postbezorger PostNL met een verlies van 0,6 procent. Uitgever Reed Elsevier stond bovenaan met een plus van 0,2 procent. In de MidKap was biotechnologiebedrijf Pharming laatste met een min van ruim 1 procent. Koploper was het Egyptische bouwbedrijf OCI met een plus van meer dan 1 procent.

Bron: IG

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Find articles by analysts

Een artikel zoeken

Form has failed to submit. Please contact IG directly.